CCWM
GSK icon

Cassaday & Co Wealth Management’s GSK GSK Stock Holding History

Cassaday & Co Wealth Management’s Portfolio GSK Stock Details GSK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$5.71K Sell
109
-25
-19% -$1.32K ﹤0.01% 936
2026
Q1 		$7.4K Buy
+134
New +$7.26K ﹤0.01% 921

Other funds holding GSK

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
JEST
JTC Employer Solutions Trustee St Helier, Jersey $1.25B AUM 41.83% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

Cassaday & Co Wealth Management's GSK Position: Q2 2026 in Review

Cassaday & Co Wealth Management reduced its GSK (GSK) stake by 19% in Q2 2026, selling an estimated $1.32K and leaving 109 shares worth $5.71K. The position accounts for ﹤0.01% of the portfolio, ranked #936.

Cassaday & Co Wealth Management first reported a position in GSK in Q1 2026 and has held it in 2 quarters since. The position peaked at $7.4K in Q1 2026. 1,037 funds tracked by Wall St. Rank hold GSK as of Q2 2026.

  • Cassaday & Co Wealth Management held 109 shares of GSK worth $5.71K as of Q2 2026.
  • Cassaday & Co Wealth Management sold 25 GSK shares in Q2 2026, an estimated $1.32K.
  • GSK made up ﹤0.01% of Cassaday & Co Wealth Management's portfolio in Q2 2026, its #936 holding.
  • Cassaday & Co Wealth Management first reported a position in GSK in Q1 2026 and has held it in 2 quarters since.
  • Cassaday & Co Wealth Management's GSK position peaked at $7.4K in Q1 2026.
  • 1,037 funds tracked by Wall St. Rank held GSK as of Q2 2026.

Based on Cassaday & Co Wealth Management's 13F filing for Q2 2026, filed 10 Aug 2026.